GLP-1 drugs, like Ozempic and Wegovy have been associated with a lower risk of cancer in diabetics according to a new study.
For patients with type 2 diabetes, taking one of the new GLP-1 drugs, such as Ozempic, is associated with lower risks of ...
GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles.
GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests.
A new study is showing that the new class of weight loss drugs like Ozempic and Wegovy may help lower the risk of 10 ...
Blockbuster weight loss and diabetes drugs may lower patients’ risk of developing some common types of cancer that are ...
Losing weight can protect you against cancers related to obesity, a new study finds. Obesity has been linked to higher risk ...
The popular class of antidiabetic and weight loss drugs known as GLP-1RAs, which includes Ozempic and Wegovy, has been found ...
Share on Pinterest A study finds that people with type 2 diabetes who took semaglutide were less likely to develop certain ...